Replimune Group, Inc. (REPL)
7.16
-0.49
(-6.41%)
USD |
NASDAQ |
Mar 02, 16:00
7.15
-0.01
(-0.14%)
After-Hours: 20:00
Replimune Group EPS Diluted (Quarterly) : -0.7694 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | -3.934 |
| Bristol Myers Squibb Co. | 0.5326 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -70.93M |
| Total Expenses (Quarterly) | 70.93M |
| Enterprise Value | 398.43M |
| Earnings Yield | -50.03% |
| Normalized Earnings Yield | -50.03 |